FIELD: medicine.
SUBSTANCE: invention is intended for prediction of risk of infectious complications in patients with malignant lymphoproliferative diseases and receiving program chemotherapy. Peripheral venous blood cell DNA is recovered and before onset of cytopenic complications from program chemotherapy and manifestation of infections, analysis of distribution of T-1237C genotypes polymorphism of TLR9 gene is carried out. Detection of CC T-1237C homozygote for TLR9 shows high risk of infections is predicted.
EFFECT: invention provides preparing new criteria for prediction of developing infectious complications in early stages of polychemotherapy.
1 cl, 1 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE RISK OF DEVELOPING COVID-19 IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES | 2022 |
|
RU2783422C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF INFECTION AND SEVERE INFECTIOUS COMPLICATIONS IN PATIENTS SUFFERING FROM HEMOBLASTOSIS RECEIVING PROGRAMMED POLYCHEMIOTHERAPY | 2000 |
|
RU2199115C2 |
| METHOD FOR PREDICTING THE PROGRESS OF PAPILLOMAVIRUS INFECTION IN PATIENTS WITH CHRONIC RECURRENT INFLUENZA ASSOCIATED CERVICITIS | 2017 |
|
RU2646785C1 |
| METHOD FOR PREDICTION OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN WOMEN WITH BREAST CANCER | 2019 |
|
RU2714683C1 |
| METHOD OF POLYCHEMOTHERAPEUTIC ENTEROPATHY PREVENTION AND TREATMENT | 2009 |
|
RU2405546C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF TOXIC HEPATITIS AT CHEMOTHERAPY OF MULTIPLE MYELOMA | 2005 |
|
RU2283494C1 |
| METHOD FOR ACCOMPANYING TREATMENT OF LYMPHOBLAST LEUCOSIS | 2006 |
|
RU2320367C1 |
| METHOD FOR DETECTION OF PRIMARY REFRACTORY FORM OF MULTIPLE MYELOMA AT THE DISEASE ONSET | 2020 |
|
RU2749612C1 |
| METHOD FOR PREDICTING INFECTIOUS COMPLICATIONS AFTER CHEMOTHERAPY IN PATIENTS WITH ACUTE LEUKOSIS | 2005 |
|
RU2315305C2 |
| METHOD FOR PREDICTION OF EARLY RELAPSE IN PATIENTS WITH HAEMOBLASTOSES FOLLOWING AUTOLOGOUS STEM HAEMOPOIETIC CELL TRANSPLANTATION | 2012 |
|
RU2498312C1 |
